Hebden T - Search Results

1

Impact of health care payer type on HIV stage of illness at time of initiation of antiretroviral therapy in the USA.

Schneider G, Juday T, Wentworth C 3rd, Lanes S, Hebden T, Seekins D. Schneider G, et al. Among authors: hebden t. AIDS Care. 2013;25(11):1470-6. doi: 10.1080/09540121.2013.774316. Epub 2013 Mar 21. AIDS Care. 2013. PMID: 23517139

2

Patterns and correlates of linkage to appropriate HIV care after HIV diagnosis in the US Medicaid population.

Johnston SS, Juday T, Seekins D, Hebden T, Fulcher N, Farr AM, Chu BC, Mullins CD. Johnston SS, et al. Among authors: hebden t. Sex Transm Dis. 2013 Jan;40(1):18-25. doi: 10.1097/OLQ.0b013e3182782014. Sex Transm Dis. 2013. PMID: 23250298

3

Comparison between guideline-preferred and nonpreferred first-line HIV antiretroviral therapy.

Johnston SS, Juday T, Farr AM, Chu BC, Hebden T. Johnston SS, et al. Among authors: hebden t. Am J Manag Care. 2014 Jun;20(6):448-55. Am J Manag Care. 2014. PMID: 25180433 Free article.

4

Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens.

Taneja C, Juday T, Gertzog L, Edelsberg J, Correll T, Hebden T, Oster G. Taneja C, et al. Among authors: hebden t. Expert Opin Pharmacother. 2012 Oct;13(15):2111-8. doi: 10.1517/14656566.2012.719875. Epub 2012 Sep 13. Expert Opin Pharmacother. 2012. PMID: 22970926

5

Cost-effectiveness of efavirenz vs rilpivirine in HIV patients initiating first-line combination antiretroviral therapy.

Bonafede M, Juday T, Lenhart G, Pan K, Hebden T, Correll T. Bonafede M, et al. Among authors: hebden t. J Med Econ. 2013;16(4):552-9. doi: 10.3111/13696998.2013.774280. Epub 2013 Feb 21. J Med Econ. 2013. PMID: 23391157 Free article.

6

Comparative incidence and health care costs of medically attended adverse effects among U.S. Medicaid HIV patients on atazanavir- or darunavir-based antiretroviral therapy.

Johnston SS, Juday T, Esker S, Espindle D, Chu BC, Hebden T, Uy J. Johnston SS, et al. Among authors: hebden t. Value Health. 2013 Mar-Apr;16(2):418-25. doi: 10.1016/j.jval.2012.10.021. Epub 2013 Jan 26. Value Health. 2013. PMID: 23538194 Free article.

7

Adherence, persistence, healthcare utilization, and cost benefits of guideline-recommended hepatitis B pharmacotherapy.

Han SH, Jing W, Mena E, Li M, Pinsky B, Tang H, Hebden T, Juday T. Han SH, et al. Among authors: hebden t. J Med Econ. 2012;15(6):1159-66. doi: 10.3111/13696998.2012.710690. Epub 2012 Jul 30. J Med Econ. 2012. PMID: 22780707 Free article.

8

Cost-effectiveness of entecavir versus adefovir for the treatment of chronic hepatitis B in patients with decompensated cirrhosis from a third-party US payer perspective.

Tsai N, Jeffers L, Cragin L, Sorensen S, Su W, Rosenblatt L, Tang H, Hebden T, Juday T. Tsai N, et al. Among authors: hebden t. Clinicoecon Outcomes Res. 2012;4:227-35. doi: 10.2147/CEOR.S31784. Epub 2012 Aug 23. Clinicoecon Outcomes Res. 2012. PMID: 22977309 Free PMC article.

9

Impact of cost-sharing on treatment augmentation in patients with depression.

Gibson TB, Jing Y, Bagalman JE, Cao Z, Bates JA, Hebden T, Forbes RA, Doshi JA. Gibson TB, et al. Among authors: hebden t. Am J Manag Care. 2012 Jan 1;18(1):e15-22. Am J Manag Care. 2012. PMID: 22435786 Free article.

10

Comparison of second-generation antipsychotic treatment on psychiatric hospitalization in Medicaid beneficiaries with bipolar disorder.

Jing Y, Johnston SS, Fowler R, Bates JA, Forbes RA, Hebden T. Jing Y, et al. Among authors: hebden t. J Med Econ. 2011;14(6):777-86. doi: 10.3111/13696998.2011.625066. Epub 2011 Sep 29. J Med Econ. 2011. PMID: 21954966 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

30 results

Search Page

Filters